Nf2 Biosolutions

990 • Fiscal year 2020 • EIN 83-0940046

Jan 01, 2020 to Dec 31, 2020

Organization Profile www.nf2biosolutions.org

West Chester, PA

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

0.16x

Higher debt load relative to assets than 66% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

0.14x

Higher debt load relative to revenue than 63% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

24%

Higher net margin than 75% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

No value available

This filing does not contain officer compensation rows.

Source year 2020

75%

Faster asset growth than 88% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2019 to 2020

58%

Faster revenue growth than 88% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2019 to 2020

Balance Sheet

Liabilities / Assets66th percentile

Assets

$638,177

Up $273,092 (+75%) from 2019

Net Assets

$536,277

Up $171,192 (+47%) from 2019

Liabilities

$101,900

Up $101,900 from 2019

Revenue And Expenses

Liabilities / Revenue63rd percentile Net Margin75th percentile

Revenue

$708,384

Up $258,733 (+58%) from 2019

Expenses

$537,191

Up $331,023 (+161%) from 2019

Net Income

Down

$171,193

Down $72,290 (-30%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth88th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

Highlighted filing

2020

Assets$638,177

Liabilities$101,900

Net Assets$536,277

Open 2020 Filing

Operations Trend

Revenue Growth88th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

Highlighted filing

2020

Revenue$708,384

Expenses$537,191

Net Income$171,193

Open 2020 Filing

Filing Detail Status

This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)

Jump To

Filing Snapshot

Filing Period: Jan 1, 2020 to Dec 31, 2020

Mission and Program Overview

Mission

Seeking a cure or preventative treatment for NF2 by vigorously supporting and advancing existing and next generation biomedical technologies such as gene transfer therapy and immunontherapy

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990Summary only. Only limited summary data is available for this year.

Open filing

Assets: $638,177
Liabilities: $101,900
Net assets: $536,277
Revenue: $708,384
Expenses: $537,191
Net income: $171,193

	Balance Sheet			Operations
Year	Assets	Liabilities	Net Assets	Revenue	Expenses	Net Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.	$6.22	$1.02	$5.20	$2.26	$3.17	$0.91
2023Summary only. Only limited summary data is available for this year.	$7.12	$1.02	$6.10	$7.72	$9.66	$1.94
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.	$9.06	$1.02	$8.05	$4.19	$3.08	$1.10
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$7.96	$1.02	$6.94	$5.44	$3.86	$1.58
2020Summary only. Only limited summary data is available for this year.	$6.38	$1.02	$5.36	$7.08	$5.37	$1.71
2019Summary only. Only limited summary data is available for this year.	$3.65	$0.00	$3.65	$4.50	$2.06	$2.43
2018Summary only. Only limited summary data is available for this year.	$1.22	$0.00	$1.22	$1.29	$0.08	$1.22